Product
Mitoquinone
Aliases
mitoquinol, Mitoquinone/mitoquinol mesylate
4 clinical trials
8 indications
Indication
frailtyIndication
Mild Cognitive ImpairmentIndication
AgingIndication
Respiratory viral infectionIndication
Antiviral TreatmentIndication
COVID-19Indication
Multiple SclerosisIndication
FatigueClinical trial
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older AdultsStatus: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate as Prophylaxis for Development of Severe Viral IllnessStatus: Completed, Estimated PCD: 2023-05-09
Clinical trial
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19Status: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
MitoQ for Fatigue in Multiple Sclerosis: a Placebo Controlled TrialStatus: Terminated, Estimated PCD: 2019-01-10